New pharmaceutical approaches to the treatment of cystic fibrosis
- 1 April 1996
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 2 (4) , 392-393
- https://doi.org/10.1038/nm0496-392
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutationsNature Medicine, 1996
- Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis MutationJournal of Biological Chemistry, 1996
- Cystic FibrosisScientific American, 1995
- A mouse model for the delta F508 allele of cystic fibrosis.Journal of Clinical Investigation, 1995
- CFTR as a cAMP-Dependent Regulator of Sodium ChannelsScience, 1995
- Generation and characterization of a ΔF508 cystic fibrosis mouse modelNature Genetics, 1995
- CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATPCell, 1995
- The amino-terminal portion of CFTR forms a regulated CI− channelCell, 1994
- MODULATION OF THE IONIC MILIEU OF THE AIRWAY IN HEALTH AND DISEASEAnnual Review of Medicine, 1994
- A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic FibrosisNew England Journal of Medicine, 1990